ML13221A393: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:From: Jim Costedio <Jim.Costedio@shinemed.com> Sent: Thursday, August 08, 2013 1:11 PM To: Lynch, Steven Cc: Moser, Michelle; Jeff Bartelme; Bill Hennessy  
{{#Wiki_filter:From:                       Jim Costedio <Jim.Costedio@shinemed.com>
Sent:                       Thursday, August 08, 2013 1:11 PM To:                         Lynch, Steven Cc:                         Moser, Michelle; Jeff Bartelme; Bill Hennessy


==Subject:==
==Subject:==
DRAFT SHINE Response to Proposed Action Request #5 Attachments: SHINE Response to Proposed Action Request #5.pdf; Attachment 18 - Figure 19.2.2-1, Revision 1.pdf Importance:
DRAFT SHINE Response to Proposed Action Request #5 Attachments:                 SHINE Response to Proposed Action Request #5.pdf; Attachment 18 - Figure 19.2.2-1, Revision 1.pdf Importance:                 High Hi Steve, I am providing you with these attachments to facilitate your discussion regarding proprietary information with AL Adams. Attached is a draft of what we plan on submitting.
High Hi Steve,  
 
I am providing you with these attachments to facilitate your discussion regarding proprietary information with AL Adams. Attached is a draft of what we plan on submitting.
Note that Reference 2 in the attached response to Proposed Action Request #5 is the SHINE Medical Technologies, Inc. letter to NRC, dated March 26, 2013, Part One of the SHINE Medical Technologies, Inc. Application for Construction Permit (ML130880226).
Note that Reference 2 in the attached response to Proposed Action Request #5 is the SHINE Medical Technologies, Inc. letter to NRC, dated March 26, 2013, Part One of the SHINE Medical Technologies, Inc. Application for Construction Permit (ML130880226).
Jim Jim Costedio Licensing Manager SHINE Medical Technologies  
Jim Jim Costedio Licensing Manager SHINE Medical Technologies 608-210-1730}}
 
608-210-1730}}

Latest revision as of 14:56, 4 November 2019

Draft Shine Response to Proposed Action Request #5
ML13221A393
Person / Time
Site: SHINE Medical Technologies
Issue date: 08/08/2013
From: Jim Costedio
SHINE Medical Technologies
To: Steven Lynch
Division of Policy and Rulemaking
Lynch S
Shared Package
ML13221A307 List:
References
Download: ML13221A393 (1)


Text

From: Jim Costedio <Jim.Costedio@shinemed.com>

Sent: Thursday, August 08, 2013 1:11 PM To: Lynch, Steven Cc: Moser, Michelle; Jeff Bartelme; Bill Hennessy

Subject:

DRAFT SHINE Response to Proposed Action Request #5 Attachments: SHINE Response to Proposed Action Request #5.pdf; Attachment 18 - Figure 19.2.2-1, Revision 1.pdf Importance: High Hi Steve, I am providing you with these attachments to facilitate your discussion regarding proprietary information with AL Adams. Attached is a draft of what we plan on submitting.

Note that Reference 2 in the attached response to Proposed Action Request #5 is the SHINE Medical Technologies, Inc. letter to NRC, dated March 26, 2013, Part One of the SHINE Medical Technologies, Inc. Application for Construction Permit (ML130880226).

Jim Jim Costedio Licensing Manager SHINE Medical Technologies 608-210-1730